Skip to content
Lower risk Drug recall · FDA · Published February 9, 2024

Apotex Fluticasone Nasal Spray Recall: Potential Burkholderia cepacia Contamination

Apotex recalls Fluticasone Propionate Nasal Spray 50mcg 120 sprays due to potential Burkholderia cepacia contamination. This may pose health risks for users with compromised immune systems.

🇺🇸 FDA recall #D-0326-2024DrugApotex ›
Take action

Contact the company

Recalling firmApotex Corp.2400 N Commerce Pkwy Ste 400 · Weston, FL 33326-3253
✎ GovInfoNow plain-language explainer

Apotex is recalling Fluticasone Propionate Nasal Spray 50mcg (120 sprays) because it may contain Burkholderia cepacia complex, a bacteria that can cause infections in people with weakened immune systems. This recall affects prescription nasal sprays sold in the U.S. with specific lot numbers and expiration dates. Read more at govinfonow.com/recall/32826-apotex-fluticasone-nasal-spray-recall-potential-burkholderia-cepacia-contamination.

Source Summary by GovInfoNow · govinfonow.com/recall/32826-apotex-fluticasone-nasal-spray-recall-potential-burkholderia-cepacia-contamination · Updated August 17, 2026 · FDA enforcement record: FDA #D-0326-2024

Cite this page

“Apotex Fluticasone Nasal Spray Recall: Potential Burkholderia cepacia Contamination.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32826-apotex-fluticasone-nasal-spray-recall-potential-burkholderia-cepacia-contamination. Based on FDA recall #D-0326-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0326-2024%22&limit=1).

The FDA announced on Feb. 9, 2024, that Apotex Corp. is voluntarily recalling Fluticasone Propionate Nasal Spray USP 50mcg due to potential presence of Burkholderia cepacia complex from CGMP deviations. The agency issued recall number D-0326-2024 for the Class II recall.

How to tell if you have it

  • Brand: Apotex
  • Product: Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill
  • NDC: 60505-0829-1
  • Lot number: TX5274
  • Expiration date: 09/30/2026
  • Quantity: 292,752 bottles

The hazard

The recall addresses CGMP deviations that may result in the potential presence of Burkholderia cepacia complex in the product. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Apotex Corp. has 24 other recalls on record since 2007-06-14. Recent Apotex actions include a Sept. 23, 2026, recall of Paroxetine 37.5mg due to dissolution failure and an Aug. 13, 2026, recall of Paxil CR 37.5mg Tablets for failed stability testing. Other recent recalls of similar products include Walgreens Saline Nasal Spray with Xylitol Recall (Nov. 12, 2025), ClearLife Allergy Nasal Spray Recall (Dec. 12, 2025), and Medinatura ReBoost Nasal Spray Recall (Dec. 12, 2025).

How to tell if you have this one

Check for the product name 'Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays' with lot number #TX5274 and expiration date 09/30/2026. The product is manufactured by Apotex Inc. in Toronto, Ontario, Canada.

  • Brand
    Apotex
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number and expiration date on the product label to confirm if it matches #TX5274 expiring 09/30/2026.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 19 days after the firm started it.

1. Firm started the recall: Feb 9, 202412. FDA classified it Class II: Feb 16, 202423. Published in FDA’s Enforcement Report: Feb 28, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is there a risk of serious injury?

The recall is for potential bacterial contamination, which could cause infections in vulnerable individuals. There is no mention of immediate physical injury risks in normal use.

Similar recalls

Other Apotex recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0326-2024 (February 9, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0326-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA